Drotrecogin Alfa (Activated) in Adults with Septic Shock

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Survival Methods· 2007 · 51 citations
2. The efficacy and safety of recombinant human activated protein C for the treatment of patients with severe sepsis (vol 28, pg 48, 2000)· 2001 · 213 citations
3. Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial· 2007 · 501 citations
4. Human recombinant activated protein C for severe sepsis· 2012 · 216 citations
5. The effect of drotrecogin alfa (activated) on long-term survival after severe sepsis *· 2004 · 154 citations